BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14628099)

  • 21. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
    Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
    Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing.
    Koort JK; Mäkinen TJ; Knuuti J; Jalava J; Aro HT
    J Nucl Med; 2004 Aug; 45(8):1406-11. PubMed ID: 15299068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation.
    Kubota K; Furumoto S; Iwata R; Fukuda H; Kawamura K; Ishiwata K
    Ann Nucl Med; 2006 Oct; 20(8):527-33. PubMed ID: 17134019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET and macro- and microautoradiographic studies combined with immunohistochemistry for monitoring rat intestinal ulceration and healing processes.
    Yamato M; Kataoka Y; Mizuma H; Wada Y; Watanabe Y
    J Nucl Med; 2009 Feb; 50(2):266-73. PubMed ID: 19164236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
    Zhao S; Kuge Y; Tsukamoto E; Mochizuki T; Kato T; Hikosaka K; Hosokawa M; Kohanawa M; Tamaki N
    Eur J Nucl Med; 2001 Jun; 28(6):730-5. PubMed ID: 11440033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
    Pellegrino D; Bonab AA; Dragotakes SC; Pitman JT; Mariani G; Carter EA
    J Nucl Med; 2005 Sep; 46(9):1522-30. PubMed ID: 16157536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
    Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
    J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
    Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS
    J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of 18F-FCH Uptake in Human T98G Glioblastoma Cells.
    Buroni FE; Pasi F; Persico MG; Lodola L; Aprile C; Nano R
    Anticancer Res; 2015 Dec; 35(12):6439-43. PubMed ID: 26637854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
    Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
    Tian M; Zhang H; Oriuchi N; Higuchi T; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1064-72. PubMed ID: 15014903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
    How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
    Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series.
    Pipitone N; Versari A; Zuccoli G; Levrini G; Macchioni P; Bajocchi G; Salvarani C
    Clin Exp Rheumatol; 2012; 30(4):570-3. PubMed ID: 22703951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.